Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy

This publication has 8 references indexed in Scilit:

• Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy
  AIDS, 2002
• Naive CD4⁺T Lymphocytes Express High Levels of Bcl-2 after Highly Active Antiretroviral Therapy for HIV Infection
  AIDS Research and Human Retroviruses, 2000
• Repeated measures in clinical trials: simple strategies for analysis using summary measures
  Statistics in Medicine, 2000
• Prediction of Imminent Complications in HIV-1–Infected Patients by Markers of Lymphocyte Apoptosis
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients
  Clinical and Experimental Immunology, 1999
• Study of Spontaneous Apoptosis in HIV⁺Patients: Correlation with Clinical Progression and T Cell Loss
  AIDS Research and Human Retroviruses, 1997
• Molecular thanatopsis: a discourse on the BCL2 family and cell death
  Blood, 1996